# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.
The move follows AlloVir’s announcement on December 22, 2023 that it is discontinuing its three global Phase 3 posoleucel studi...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
B of A Securities analyst Jason Zemansky downgrades AlloVir (NASDAQ:ALVR) from Buy to Underperform and lowers the price targ...
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Friday. The Dow traded down 0.05...
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.